Scarica l'app Stockscreener
38.41
0.26%
-0.10
Dopo l'orario di chiusura:
38.41
Precedente Chiudi:
$38.51
Aprire:
$38.13
Volume 24 ore:
471.83K
Relative Volume:
0.87
Capitalizzazione di mercato:
$1.91B
Reddito:
$499.95M
Utile/perdita netta:
$-36.36M
Rapporto P/E:
-49.88
EPS:
-0.77
Flusso di cassa netto:
$24.22M
1 W Prestazione:
-0.03%
1M Prestazione:
-4.76%
6M Prestazione:
+21.94%
1 anno Prestazione:
-5.95%
Intervallo 1D:
$37.35
$39.28
Intervallo di 1 settimana:
$37.35
$40.91
Portata 52W:
$28.29
$43.18
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Confronta ATRC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
38.41 | 1.91B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
525.04 | 187.46B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.40 | 57.96B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.87 | 39.68B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.31 | 37.32B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.50 | 37.29B | 5.26B | 1.44B | 1.76B | 9.7713 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
Riverwater Partners LLC Buys 26,657 Shares of AtriCure, Inc. $ATRC - MarketBeat
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results - Business Wire
The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices - Yahoo Finance
Market Pulse: Is AtriCure Inc stock trending bullish2025 Investor Takeaways & Real-Time Volume Spike Alerts - baoquankhu1.vn
SG Americas Securities LLC Has $824,000 Position in AtriCure, Inc. $ATRC - MarketBeat
(ATRC) Risk Channels and Responsive Allocation - Stock Traders Daily
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
AtriCure (ATRC) Is Down 5.8% After Issuing 2026 Profitability Guidance And Expanding Credit Facility - Yahoo Finance
What are AtriCure Incs recent SEC filings showingMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results - Nasdaq
AI Diagnostics: The End of the High-Cost Imaging Era - GlobeNewswire
AtriCure Stock (+11%): Profitability Inflection Ignites Re-Rate - Trefis
AtriCure (NASDAQ:ATRC) Trading 6.7% HigherHere's Why - MarketBeat
AtriCure Inc (ATRC) Shares Up 8.49% on Jan 15 - GuruFocus
AtriCure CEO Touts $10B AFib and Pain Market, Raises EBITDA Outlook at JPMorgan Conference - MarketBeat
Momentum Shift: Is AtriCure Inc a potential multi baggerRate Cut & Reliable Price Action Trade Plans - baoquankhu1.vn
ATRC: Innovation and clinical evidence drive growth in AFib and pain management, with strong financial results - TradingView
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX) - The Globe and Mail
Street Watch: What is AtriCure Incs revenue forecastBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn
AtriCure reports 13% revenue growth in Q4 2025, provides 2026 outlook - Investing.com Nigeria
AtriCure, Inc. (ATRC) Investor Outlook: Analyzing A 40% Potential Upside - DirectorsTalk Interviews
AtriCure (NASDAQ:ATRC) Shares Down 7.6%Time to Sell? - MarketBeat
AtriCure, Inc. and AtriCure, LLC Enter into a First Amendment to Credit Agreement - marketscreener.com
ATRC: Projected Strong Revenue and Growth by 2026 - GuruFocus
AtriCure reports 13% revenue growth in Q4 2025, provides 2026 outlook By Investing.com - Investing.com South Africa
AtriCure (NASDAQ:ATRC) Releases Q4 2025 Earnings Guidance - MarketBeat
AtriCure (ATRC) Anticipates Strong Revenue Growth in Q4 2025 - GuruFocus
AtriCure's preliminary Q4 revenue rises 13%, slightly beats estimates - TradingView
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 - FinancialContent
AtriCure Reports Strong Preliminary 2025 Revenue Growth - TipRanks
AtriCure IncEnters first amendment to credit agreementSEC filing - marketscreener.com
AtriCure Signs First Amendment to Credit Agreement With JPMorgan Chase Bank - TradingView — Track All Markets
A Look At AtriCure (ATRC) Valuation As Earnings Beats And Analyst Optimism Lift Confidence - simplywall.st
Jobs Data: Why is AtriCure Inc stock going down2025 Fundamental Recap & Stock Portfolio Risk Management - baoquankhu1.vn
AtriCure, Inc. (ATRC) soars to 52-week high, time to cash out? - MSN
Will AtriCure Inc. stock benefit from green energy trendsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Улправда
(ATRC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
AtriCure, Inc. (ATRC) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Is AtriCure Inc. stock a defensive play in 2025July 2025 Movers & Fast Gaining Stock Strategy Reports - Улправда
Will AtriCure Inc. stock benefit from automationJuly 2025 Short Interest & High Return Trade Guides - Улправда
Will AtriCure Inc. stock continue upward momentumQuarterly Risk Review & AI Powered Trade Plan Recommendations - Улправда
Will AtriCure Inc. stock attract ESG investorsJuly 2025 Breakouts & High Accuracy Trade Alerts - Улправда
AtriCure (NASDAQ:ATRC) Reaches New 12-Month HighWhat's Next? - MarketBeat
AtriCure stock hits 52-week high at $43.18 By Investing.com - Investing.com Canada
AtriCure stock hits 52-week high at $43.18 - Investing.com
Fed Watch: How risky is AtriCure Inc. stock nowJuly 2025 Earnings & Comprehensive Market Scan Insights - Улправда
Is AtriCure Inc. stock trading at a premium valuation2025 Earnings Impact & Community Trade Idea Sharing Platform - Улправда
AtriCure (NASDAQ:ATRC) Upgraded at Zacks Research - MarketBeat
AtriCure (NASDAQ:ATRC) Share Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Nasdaq Index Fund Medical Devices - Kalkine Media
AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriCl - PharmiWeb.com
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):